Adial pharmaceuticals awarded new patent from the united states patent and trademark office

New patent strengthens adial's patent portfolio and covers ad04's unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder new patent strengthens adial's patent portfolio and covers ad04's unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder
ADIL Ratings Summary
ADIL Quant Ranking